Bukwang Pharmaceutical Co., Ltd. total revenue, net income and dynamics of changes in South Korean won today
Bukwang Pharmaceutical Co., Ltd. current income and income for the latest reporting periods. The dynamics of Bukwang Pharmaceutical Co., Ltd. net revenue fell by -12 608 932 830 ₩ compared to the previous report. Net income, revenue and dynamics - the main financial indicators of Bukwang Pharmaceutical Co., Ltd.. The financial report chart on our website displays information by dates from 31/03/2019 to 31/03/2021. All information on Bukwang Pharmaceutical Co., Ltd. total revenue on this chart is created in the form of yellow bars. The value of Bukwang Pharmaceutical Co., Ltd. assets on the online chart is displayed in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
The latest dates of Bukwang Pharmaceutical Co., Ltd. financial statements available online: 31/03/2019, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest date of the financial report of Bukwang Pharmaceutical Co., Ltd. is 31/03/2021. Gross profit Bukwang Pharmaceutical Co., Ltd. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Bukwang Pharmaceutical Co., Ltd. is 16 870 819 590 ₩
Cost of revenue Bukwang Pharmaceutical Co., Ltd. is the total cost of producing and distributing of products and services of a company. Cost of revenue Bukwang Pharmaceutical Co., Ltd. is 19 985 836 240 ₩ Total revenue Bukwang Pharmaceutical Co., Ltd. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Bukwang Pharmaceutical Co., Ltd. is 36 856 655 830 ₩ Operating income Bukwang Pharmaceutical Co., Ltd. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Bukwang Pharmaceutical Co., Ltd. is -2 085 907 250 ₩
Net income Bukwang Pharmaceutical Co., Ltd. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Bukwang Pharmaceutical Co., Ltd. is -3 216 472 480 ₩ Current assets Bukwang Pharmaceutical Co., Ltd. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Bukwang Pharmaceutical Co., Ltd. is 245 116 748 760 ₩ Total assets Bukwang Pharmaceutical Co., Ltd. refers to the total amount of assets owned by a person or entity. Total assets Bukwang Pharmaceutical Co., Ltd. is 391 267 146 490 ₩
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
16 870 819 590 ₩
21 315 887 240 ₩
15 407 457 980 ₩
16 724 855 700 ₩
25 600 824 900 ₩
18 419 039 260 ₩
20 361 812 860 ₩
18 970 159 720 ₩
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
19 985 836 240 ₩
28 149 701 420 ₩
24 942 386 650 ₩
25 313 903 150 ₩
25 783 955 580 ₩
21 320 711 030 ₩
20 824 022 870 ₩
16 913 089 840 ₩
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
36 856 655 830 ₩
49 465 588 660 ₩
40 349 844 630 ₩
42 038 758 850 ₩
51 384 780 480 ₩
39 739 750 290 ₩
41 185 835 730 ₩
35 883 249 560 ₩
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
51 384 780 480 ₩
39 739 750 290 ₩
41 185 835 730 ₩
35 883 249 560 ₩
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-2 085 907 250 ₩
2 129 263 780 ₩
102 529 410 ₩
1 039 975 990 ₩
6 119 879 630 ₩
-2 081 738 030 ₩
3 840 883 660 ₩
1 658 401 450 ₩
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-3 216 472 480 ₩
-1 554 415 900 ₩
-6 156 849 910 ₩
1 452 685 170 ₩
5 788 847 250 ₩
-3 480 018 600 ₩
-12 421 602 220 ₩
2 700 405 750 ₩
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
6 799 026 000 ₩
6 524 314 000 ₩
3 633 953 000 ₩
3 706 303 770 ₩
5 110 371 510 ₩
4 888 169 690 ₩
2 903 137 660 ₩
4 410 546 140 ₩
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
38 942 563 080 ₩
47 336 324 880 ₩
40 247 315 220 ₩
40 998 782 860 ₩
45 264 900 850 ₩
41 821 488 320 ₩
37 344 952 070 ₩
34 224 848 110 ₩
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
245 116 748 760 ₩
248 209 344 940 ₩
246 164 564 720 ₩
252 592 471 710 ₩
186 397 967 480 ₩
185 499 277 050 ₩
194 253 603 970 ₩
239 659 039 000 ₩
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
391 267 146 490 ₩
400 968 741 560 ₩
405 225 145 790 ₩
425 335 989 220 ₩
388 534 557 100 ₩
378 935 483 810 ₩
401 981 384 330 ₩
481 066 798 000 ₩
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
92 196 914 640 ₩
79 290 779 900 ₩
81 991 652 660 ₩
80 064 836 280 ₩
37 584 814 360 ₩
51 789 631 320 ₩
62 481 108 190 ₩
113 006 175 000 ₩
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
35 883 740 860 ₩
27 293 134 850 ₩
47 944 302 830 ₩
40 442 343 000 ₩
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
62 048 555 730 ₩
57 046 866 060 ₩
76 951 156 720 ₩
76 157 774 000 ₩
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
15.97 %
15.05 %
19.14 %
15.83 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
248 573 417 510 ₩
258 499 091 270 ₩
275 420 877 020 ₩
286 880 434 140 ₩
326 246 221 480 ₩
321 700 954 540 ₩
325 010 209 080 ₩
404 883 237 000 ₩
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-8 363 339 170 ₩
-705 869 440 ₩
-6 721 642 010 ₩
-7 616 657 000 ₩
Last revenue report of Bukwang Pharmaceutical Co., Ltd. was 31/03/2021. According to last financial report total revenue in Bukwang Pharmaceutical Co., Ltd. was 36 856 655 830 South Korean won and changed by +2.71% since last year. Net income in Bukwang Pharmaceutical Co., Ltd. was -3 216 472 480 ₩ in last quartal, net income changes to -219.111%.
Current cash Bukwang Pharmaceutical Co., Ltd. - the sum of all of the cash a company has on the date of report. Current cash Bukwang Pharmaceutical Co., Ltd. is 92 196 914 640 ₩
